| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Administration of first dose of tetanus vaccine |
Direct substance |
False |
anatoxine tétanique |
Inferred relationship |
Some |
1 |
| Administration of second dose of tetanus vaccine |
Direct substance |
False |
anatoxine tétanique |
Inferred relationship |
Some |
1 |
| Administration of third dose of tetanus vaccine |
Direct substance |
False |
anatoxine tétanique |
Inferred relationship |
Some |
1 |
| Administration of booster dose of tetanus vaccine |
Direct substance |
False |
anatoxine tétanique |
Inferred relationship |
Some |
1 |
| Administration of final dose of vaccine product containing only Clostridium tetani antigen (procedure) |
Direct substance |
False |
anatoxine tétanique |
Inferred relationship |
Some |
1 |
| Equine rhinopneumonitis - influenza vaccine - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Intramuscular injection of human tetanus immunoglobulin |
Direct substance |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| seringue préremplie de 0,5mL avec une suspension injectable du vaccin adsorbé contre la diphtérie et le tétanos |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| seringue préremplie de 0,5mL avec une suspension injectable du vaccin adsorbé (pour adultes et adolescents) contre la diphtérie et le tétanos |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| ampoule de 0,5 mL d'une suspension injectable du vaccin adsorbé (pour adultes et adolescents) contre la diphtérie et le tétanos |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| flacon de 0,5 mL d'une suspension injectable du vaccin adsorbé (pour adultes et adolescents) contre la diphtérie et le tétanos |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| T tétanos non spécifié |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| seringue préremplie avec une solution injectable du vaccin antitétanique adsorbé |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre Haemophilus influenzae de type B (Hib), la diphtérie, le tétanos et la coqueluche, flacon et seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre Haemophilus Influenzae de type B (Hib), la diphtérie, le tétanos et la coqueluche, seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre Haemophilus influenzae de type B (Hib), la diphtérie, le tétanos et la coqueluche, flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| flacon d'une suspension injectable du vaccin adsorbé contre la diphtérie et le tétanos |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| ampoule d'une solution injectable du vaccin contre le tétanos adsorbé |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie et le tétanos |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxines diphtérique et tétanique et vaccin à bacilles entiers contre la coqueluche |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxines diphtérique et tétanique et vaccin acellulaire contre la coqueluche |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Administration of tetanus vaccine |
Direct substance |
False |
anatoxine tétanique |
Inferred relationship |
Some |
1 |
| Tetanus antitoxin, animal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxine tétanique humaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxine tétanique, vaccin contre l'influenza et contre l'encéphalomyélite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Diphtheria and tetanus toxoids with pertussis, combined vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxine tétanique adsorbée |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| dT diphtérie + tétanos adulte non spécifié |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Equine influenza vaccine - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Vaccine product containing Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Clostridium perfringens type D - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Tetanus toxoid, animal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre l'encéphalomyélite et anatoxine tétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Tetanus vaccination NOS |
Direct substance |
False |
anatoxine tétanique |
Inferred relationship |
Some |
1 |
| ampoule de 0,5 mL d'une solution injectable de 20 U/mL d'anatoxine tétanique adsorbée |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxines diphtérique et tétanique 0,6 mL et vaccin conjugué contre Haemophilus influenzae de type b 0,5 mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 7.5ml/5ml (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxines diphtérique et tétanique, flacon de 0,5 mL et vaccin conjugué contre Haemophilus influenzae de type b, flacon d'une suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Diphtheria toxoid adsorbed ns/pertussis adsorbed ns/tetanus toxoid adsorbed ns injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| flacon de 7,5 mL du vaccin injectable adsorbé contre la diphtérie, le tétanos et la coqueluche |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| flacon de 0,5 mL d'une suspension injectable intramusculaire de 10 unités d'anatoxine tétanique adsorbée |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| seringue de 0,5 mL d'une suspension injectable intramusculaire de 10 UI d'anatoxine tétanique adsorbée |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| flacon de 0,5 mL d'un vaccin adsorbé injectable contre la diphtérie, le tétanos et la coqueluche |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Tetanus toxoid fluid |
Is a |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxines tétanique et diphtérique |
Is a |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, la coqueluche, le tétanos et Haemophilus influenzae de type B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos et inactivé contre la poliomyélite, seringue préremplie de 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos et la poliomyélite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos et la poliomyélite (inactivé) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, la coqueluche, le tétanos et la poliomyélite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, la coqueluche, le tétanos et la poliomyélite (inactivé) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos, la coqueluche et inactivé contre la poliomyélite, seringue préremplie de 0,5 mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, la coqueluche, le tétanos, la polio et Haemophilus influenzae de type b |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite et contre Haemophilus influenzae type b, fiole de 0,5 mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxines diphtérique et tétanique et vaccin à bacilles entiers contre la coqueluche |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin à faible dose contre la diphtérie, le tétanos, la coqueluche et inactivé contre la poliomyélite, seringue préremplie de 0,5 mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin à dose élevée contre la diphtérie, le tétanos, la coqueluche et inactivé contre la poliomyélite, seringue préremplie de 0,5 mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| flacon de 0,5 mL d'anatoxine tétanique, d'anatoxine diphtérique réduite, vaccin acellulaire injectable anticoquelucheux |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos et la coqueluche |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| seringue préremplie de 0,5 mL avec une suspension injectable d'antigène de surface du virus de l'hépatite B recombinant 10 microgrammes, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, vaccin acellulaire contre la coqueluche 25 microgrames |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| seringue pré-remplie de 0,5 mL avec une solution injectable de 30 UI d'anatoxine diphtérique, 40 UI d'anatoxine tétanique, 25 microgrammes du vaccin acellulaire contre la coqueluche |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre Haemophilus influenzae de type B et contre le tétanos |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| 10 microgrammes de polysaccharides contre l'Haemophilus influenzae et 24 microgrammes d'anatoxine tétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| flacon et diluant contenant une poudre pour solution injectable polysaccharidique de 10 microgrammes contre l'Haemophilus influenzae b, 30 microgrammes d'anatoxine tétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche acellulaire 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos, la coqueluche et l'hépatite B recombinant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite et de l'hépatite B recombinant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite, l'hépatite B (recombinant) et Haemophilus influenzae de type B (recombinant) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, vaccin acellulaire contre la coqueluche 25 µg, vaccin antipoliomyélitique inactivé, seringue préremplie de 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
| vaccin contre la diphtérie, le tétanos et Haemophilus influenzae de type B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine tétanique |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]